99 related articles for article (PubMed ID: 18500241)
1. Lentivector targeting to dendritic cells.
Ageichik A; Collins MK; Dewannieux M
Mol Ther; 2008 Jun; 16(6):1008-9. PubMed ID: 18500241
[No Abstract] [Full Text] [Related]
2. Lentiviral vectors for immunization: an inflammatory field.
Pincha M; Sundarasetty BS; Stripecke R
Expert Rev Vaccines; 2010 Mar; 9(3):309-21. PubMed ID: 20218859
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
Mossoba ME; Medin JA
Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo.
Zarei S; Abraham S; Arrighi JF; Haller O; Calzascia T; Walker PR; Kündig TM; Hauser C; Piguet V
J Virol; 2004 Jul; 78(14):7843-5. PubMed ID: 15220461
[TBL] [Abstract][Full Text] [Related]
5. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.
Esslinger C; Chapatte L; Finke D; Miconnet I; Guillaume P; Lévy F; MacDonald HR
J Clin Invest; 2003 Jun; 111(11):1673-81. PubMed ID: 12782670
[TBL] [Abstract][Full Text] [Related]
6. Novel immunotherapeutic approaches in targeting dendritic cells with virus vectors.
de Andrade Pereira B; Fraefel C
Discov Med; 2015 Sep; 20(109):111-9. PubMed ID: 26463092
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell, the immunotherapeutic cell for cancer.
Nagaraj S; Ziske C; Schmidt-Wolf IG
Indian J Med Res; 2004 Apr; 119(4):133-8. PubMed ID: 15147117
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
Yang HG; Hu BL; Xiao L; Wang P
Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
[TBL] [Abstract][Full Text] [Related]
9. Generation of dendritic cells from lentiviral vector-transduced CD34+ cells from HIV+ donors.
Gruber A; Chen I; Kuhen KL; Wheat JC; Law P; Wong-Staal F
J Med Virol; 2003 Jun; 70(2):183-6. PubMed ID: 12696103
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
11. Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.
Wang H; Zhang L; Kung SK
Immunotherapy; 2010 Sep; 2(5):685-95. PubMed ID: 20874652
[TBL] [Abstract][Full Text] [Related]
12. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells.
Zhang L; Tang Y; Akbulut H; Zelterman D; Linton PJ; Deisseroth AB
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15101-6. PubMed ID: 14645711
[TBL] [Abstract][Full Text] [Related]
13. Viral vectors for dendritic cell-based immunotherapy.
Jenne L; Schuler G; Steinkasserer A
Trends Immunol; 2001 Feb; 22(2):102-7. PubMed ID: 11286712
[TBL] [Abstract][Full Text] [Related]
14. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
[TBL] [Abstract][Full Text] [Related]
15. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep.
de Gruijl TD; van de Ven R
Adv Cancer Res; 2012; 115():147-220. PubMed ID: 23021245
[TBL] [Abstract][Full Text] [Related]
16. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors.
Esslinger C; Romero P; MacDonald HR
Hum Gene Ther; 2002 Jun; 13(9):1091-100. PubMed ID: 12067442
[TBL] [Abstract][Full Text] [Related]
17. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
18. Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells.
Gennari F; Lopes L; Verhoeyen E; Marasco W; Collins MK
Hum Gene Ther; 2009 Jun; 20(6):554-62. PubMed ID: 19260768
[TBL] [Abstract][Full Text] [Related]
19. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
Koya RC; Kimura T; Ribas A; Rozengurt N; Lawson GW; Faure-Kumar E; Wang HJ; Herschman H; Kasahara N; Stripecke R
Mol Ther; 2007 May; 15(5):971-80. PubMed ID: 17375074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
